User:Patrick Wiencek/AHNAK

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 42: Line 42:
PKB will phosphorylate serine 5535 in AHNAK’s C-terminal domain <sup>[6]</sup>. This will activate AHNAK’s nuclear export signal, allowing it to move out of the nucleus. AHNAK’s nuclear export signal is made up of 5 different motifs in the C-terminal domain: (4971-4979), (5019-5027), (5034-5039), (5706-5716), and (5772-5779) <sup>[18]</sup>.
PKB will phosphorylate serine 5535 in AHNAK’s C-terminal domain <sup>[6]</sup>. This will activate AHNAK’s nuclear export signal, allowing it to move out of the nucleus. AHNAK’s nuclear export signal is made up of 5 different motifs in the C-terminal domain: (4971-4979), (5019-5027), (5034-5039), (5706-5716), and (5772-5779) <sup>[18]</sup>.
*'''Protein Kinase C α (PKCα)'''
*'''Protein Kinase C α (PKCα)'''
-
PKCα will bind to and is activated by AHNAK <sup>[19]</sup>. This interaction occurs in AHNAK’s central repetitive domain (3859-4412).
+
PKCα will bind to and is activated by AHNAK <sup>[19]</sup>. This interaction occurs in AHNAK’s central repeated domain (3859-4412).
*'''Phospholipase C γ (PLCγ)'''
*'''Phospholipase C γ (PLCγ)'''
-
PLCγ will bind AHNAK in its central repetitive domain in residues 3740-3882 and 3859-4412 <sup>[20]</sup>. AHNAK also activated bound PLCγ.
+
PLCγ will bind AHNAK in its central repeated domain in residues 3740-3882 and 3859-4412 <sup>[20]</sup>. AHNAK also activated bound PLCγ.
*'''Regulatory Samds (R-Smads)'''
*'''Regulatory Samds (R-Smads)'''
The MH2 domain of Smad2 will bind to the central repetitive domain of AHNAK from residues 4105-4633 <sup>[21]</sup>.
The MH2 domain of Smad2 will bind to the central repetitive domain of AHNAK from residues 4105-4633 <sup>[21]</sup>.

Revision as of 20:22, 3 May 2018

AHNAK

Caption for this structure

Drag the structure with the mouse to rotate

References

1. Davis, T. A., Loos, B. & Engelbrecht, A.-M. AHNAK: the giant jack of all trades. Cell. Signal. 26, 2683–2693 (2014).

2. Hashimoto, T. et al. Desmoyokin, a 680 kDa keratinocyte plasma membrane-associated protein, is homologous to the protein encoded by human gene AHNAK. J. Cell Sci. 105 ( Pt 2), 275–286 (1993).

3. Chen, B. et al. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer. J. Exp. Clin. Cancer Res. CR 36, 65 (2017).

4. Zhao, Z. et al. AHNAK as a Prognosis Factor Suppresses the Tumor Progression in Glioma. J. Cancer 8, 2924–2932 (2017).

5. Davis, T. et al. Doxorubicin resistance in breast cancer: A novel role for the human protein AHNAK. Biochem. Pharmacol. 148, 174–183 (2018).

6. Sussman, J., Stokoe, D., Ossina, N. & Shtivelman, E. Protein kinase B phosphorylates AHNAK and regulates its subcellular localization. J. Cell Biol. 154, 1019–1030 (2001).

7. Benaud, C. et al. AHNAK interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitecture. J. Cell Biol. 164, 133–144 (2004).

8. Shtivelman, E., Cohen, F. E. & Bishop, J. M. A human gene (AHNAK) encoding an unusually large protein with a 1.2-microns polyionic rod structure. Proc. Natl. Acad. Sci. U. S. A. 89, 5472–5476 (1992).

9. Cell atlas - AHNAK - The Human Protein Atlas. Available at: http://www.proteinatlas.org/ENSG00000124942-AHNAK/cell. (Accessed: 30th April 2018)

10. Komuro, A. et al. The AHNAKs are a class of giant propeller-like proteins that associate with calcium channel proteins of cardiomyocytes and other cells. Proc. Natl. Acad. Sci. 101, 4053–4058 (2004).

11. Lee, H.-J. & Zheng, J. J. PDZ domains and their binding partners: structure, specificity, and modification. Cell Commun. Signal. 8, 8 (2010).

12. de Morrée, A. et al. Self-regulated alternative splicing at the AHNAK locus. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 26, 93–103 (2012).

13. Hohaus, A. et al. The carboxyl-terminal region of ahnak provides a link between cardiac L-type Ca2+ channels and the actin-based cytoskeleton. FASEB J. 16, 1205–1216 (2002).

14. Huang, Y. et al. Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle. Hum. Mol. Genet. 17, 1855–1866 (2008).

15. Huang, Y. et al. AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration. FASEB J. 21, 732–742 (2006).

16. Stiff, T., Shtivelman, E., Jeggo, P. & Kysela, B. AHNAK interacts with the DNA ligase IV-XRCC4 complex and stimulates DNA ligase IV-mediated double-stranded ligation. DNA Repair 3, 245–256 (2004).

17. EMBOSS Needle < Pairwise Sequence Alignment < EMBL-EBI. Available at: https://www.ebi.ac.uk/Tools/psa/emboss_needle/. (Accessed: 2nd May 2018)

18. AHNAK - Neuroblast differentiation-associated protein AHNAK - Homo sapiens (Human) - AHNAK gene & protein. Available at: https://www.uniprot.org/uniprot/Q09666#ptm_processing. (Accessed: 1st May 2018)

19. Lee, I. H. et al. Ahnak Protein Activates Protein Kinase C (PKC) through Dissociation of the PKC-Protein Phosphatase 2A Complex. J. Biol. Chem. 283, 6312–6320 (2008).

20. Sekiya, F., Bae, Y. S., Jhon, D. Y., Hwang, S. C. & Rhee, S. G. AHNAK, a Protein That Binds and Activates Phospholipase C-γ1 in the Presence of Arachidonic Acid. J. Biol. Chem. 274, 13900–13907 (1999).

21. Lee, I. H. et al. Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway. Oncogene 33, 4675–4684 (2014).

22. Grieve, A. G., Moss, S. E. & Hayes, M. J. Annexin A2 at the Interface of Actin and Membrane Dynamics: A Focus on Its Roles in Endocytosis and Cell Polarization. International Journal of Cell Biology (2012). Available at: https://www.hindawi.com/journals/ijcb/2012/852430/. (Accessed: 2nd May 2018)

23. Rezvanpour, A., Santamaria-Kisiel, L. & Shaw, G. S. The S100A10-Annexin A2 Complex Provides a Novel Asymmetric Platform for Membrane Repair. J. Biol. Chem. 286, 40174–40183 (2011).

24. Chang, F. et al. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17, 1263–1293 (2003).

25. Boxberg, Y. V. et al. Spinal cord injury-induced up-regulation of AHNAK, expressed in cells delineating cystic cavities, and associated with neoangiogenesis. Eur. J. Neurosci. 24, 1031–1041 (2006).

26. Salim, C., Boxberg, Y. V., Alterio, J., Féréol, S. & Nothias, F. The giant protein AHNAK involved in morphogenesis and laminin substrate adhesion of myelinating Schwann cells. Glia 57, 535–549 (2009).

27. Gentil, B. J. et al. Specific AHNAK expression in brain endothelial cells with barrier properties. J. Cell. Physiol. 203, 362–371 (2005).

28. Shin, J. H. et al. Increased Cell Proliferations and Neurogenesis in the Hippocampal Dentate Gyrus of Ahnak Deficient Mice. Neurochem. Res. 40, 1457–1462 (2015).

29. Dempsey, B. R. et al. Structure of an Asymmetric Ternary Protein Complex Provides Insight for Membrane Interaction. Structure 20, 1737–1745 (2012).

30. Shankar, J. et al. Pseudopodial Actin Dynamics Control Epithelial-Mesenchymal Transition in Metastatic Cancer Cells. Cancer Res. 70, 3780–3790 (2010).

31. Alvarez, J. et al. Calcium Current in Rat Cardiomyocytes Is Modulated by the Carboxyl-terminal Ahnak Domain. J. Biol. Chem. 279, 12456–12461 (2004).

32. Matza, D. et al. A Scaffold Protein, AHNAK1, Is Required for Calcium Signaling during T Cell Activation. Immunity 28, 64–74 (2008).

33. Matza, D. et al. Requirement for AHNAK1-mediated calcium signaling during T lymphocyte cytolysis. Proc. Natl. Acad. Sci. 106, 9785–9790 (2009).

34. Chien, A. J. et al. Roles of a Membrane-localized βSubunit in the Formation and Targeting of Functional L-type Ca2+ Channels. J. Biol. Chem. 270, 30036–30044 (1995).

35. Borgonovo, B. et al. Regulated exocytosis: a novel, widely expressed system. Nat. Cell Biol. 4, 955–963 (2002).

36. Lennon, N. J. et al. Dysferlin Interacts with Annexins A1 and A2 and Mediates Sarcolemmal Wound-healing. J. Biol. Chem. 278, 50466–50473 (2003).

37. Kouno, M. et al. Ahnak/Desmoyokin Is Dispensable for Proliferation, Differentiation, and Maintenance of Integrity in Mouse Epidermis. J. Invest. Dermatol. 123, 700–707 (2004).

38. Su, J. et al. A novel atlas of gene expression in human skeletal muscle reveals molecular changes associated with aging. Skelet. Muscle 5, 35 (2015).

39. de Magalhães, J. P., Curado, J. & Church, G. M. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinforma. Oxf. Engl. 25, 875–881 (2009).

40. Parikh, H. et al. Molecular correlates for maximal oxygen uptake and type 1 fibers. Am. J. Physiol.-Endocrinol. Metab. 294, E1152–E1159 (2008).

41. Sudo, H. et al. AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma. Int. J. Oncol. 44, 530–538 (2014).

42. Heldin, C.-H., Landström, M. & Moustakas, A. Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial–mesenchymal transition. Curr. Opin. Cell Biol. 21, 166–176 (2009).

43. Kim, I. Y. et al. 1H NMR-based metabolomic study on resistance to diet-induced obesity in AHNAK knock-out mice. Biochem. Biophys. Res. Commun. 403, 428–434 (2010).

44. Shin, J. H. et al. Obesity Resistance and Enhanced Insulin Sensitivity in Ahnak -/- Mice Fed a High Fat Diet Are Related to Impaired Adipogenesis and Increased Energy Expenditure. PLoS ONE 10, (2015).

45. AceView: Gene:AHNAK, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView. Available at: https://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/av.cgi?db=human&c=Gene&l=AHNAK. (Accessed: 30th April 2018)

46. Gillespie, C. S., Sherman, D. L., Blair, G. E. & Brophy, P. J. Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron 12, 497–508 (1994).

47. Dytrych, L., Sherman, D. L., Gillespie, C. S. & Brophy, P. J. Two PDZ Domain Proteins Encoded by the Murine Periaxin Gene Are the Result of Alternative Intron Retention and Are Differentially Targeted in Schwann Cells. J. Biol. Chem. 273, 5794–5800 (1998).

48. Han, H. & Kursula, P. Periaxin and AHNAK nucleoprotein 2 form intertwined homodimers through domain swapping. J. Biol. Chem. 289, 14121–14131 (2014).

49. Ozorowski, G., Milton, S. & Luecke, H. Structure of a C-terminal AHNAK peptide in a 1:2:2 complex with S100A10 and an acetylated N-terminal peptide of annexin A2. Acta Crystallogr. D Biol. Crystallogr. 69, 92–104 (2013).

50. Oh, Y.-S. et al. SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. Cell 152, 831–843 (2013).


Proteopedia Page Contributors and Editors (what is this?)

Patrick Wiencek

Personal tools